文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

身心疗法用于阿片类药物治疗的疼痛:一项系统评价与Meta分析

Mind-Body Therapies for Opioid-Treated Pain: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Intern Med · 2020-01-01
一句话结论系统评价与Meta分析显示,身心疗法(MBTs)与疼痛中度改善(Cohen d=-0.51)及阿片类药物剂量小幅降低(Cohen d=-0.26)相关。

该系统评价与Meta分析检索MEDLINE、Embase、Emcare、CINAHL、PsycINFO及Cochrane Library等多个数据库,检索时间自建库至2018年3月,纳入60篇报告(6404例成人临床疼痛患者)的随机临床试验。结果显示,MBTs与疼痛降低(Cohen d=-0.51;95%CI,-0.76至-0.26)及阿片类药物剂量降低(Cohen d=-0.26;95%CI,-0.44至-0.08)相关。冥想、催眠、暗示及认知行为疗法在疼痛结局上呈现中度至较大效应量改善。多数冥想、认知行为疗法及催眠研究显示阿片相关结局改善。作者认为MBTs可能与疼痛中度改善及阿片剂量小幅降低相关,并可能对阿片渴求与误用等阿片相关问题有治疗获益。

要点

  • 在成人临床疼痛且处方阿片类药物的患者中,MBTs与疼痛降低相关(Cohen d=-0.51;95%CI,-0.76至-0.26)。
  • MBTs与阿片类药物剂量降低相关(Cohen d=-0.26;95%CI,-0.44至-0.08)。
  • 冥想(Cohen d=-0.70)、催眠(Cohen d=-0.54)、暗示(Cohen d=-0.68)及认知行为疗法(Cohen d=-0.43)在疼痛结局上呈现中度至较大效应量改善,其他MBTs未见此类改善。
  • 多数冥想研究(4/5,80%)、认知行为疗法研究(4/7,57%)及催眠研究(12/25,63%)报告阿片相关结局改善,而暗示、引导想象及放松研究报告此类改善者较少。
  • 作者认为MBTs可能与疼痛中度改善及阿片剂量小幅降低相关,并可能对阿片渴求与误用等阿片相关问题有治疗获益。

适用人群与场景

  • 成人临床疼痛患者,同时处方阿片类药物,涵盖急性、操作性及慢性疼痛状况。

处置流程与药物剂量

  • 研究的MBTs干预包括冥想(n=5)、催眠(n=25)、放松(n=14)、引导想象(n=7)、治疗性暗示(n=6)及认知行为疗法(n=7)。

研究设计与关键结果

  • 系统评价与Meta分析共纳入60篇报告、6404例参与者;检索4212篇文献。
  • MBTs与疼痛降低相关(Cohen d=-0.51;95%CI,-0.76至-0.26)。
  • MBTs与阿片剂量降低相关(Cohen d=-0.26;95%CI,-0.44至-0.08)。
  • 冥想(Cohen d=-0.70)、催眠(Cohen d=-0.54)、暗示(Cohen d=-0.68)及认知行为疗法(Cohen d=-0.43)在疼痛结局上呈现中度至较大效应量改善,其他MBTs未见此类改善。
  • 多数冥想研究(4/5,80%)、认知行为疗法研究(4/7,57%)及催眠研究(12/25,63%)报告阿片相关结局改善,暗示、引导想象及放松研究报告此类改善者较少。
  • 多数MBT研究使用活性或安慰剂对照,并被判定为低偏倚风险。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入随机临床试验。
  • 局限:作者指出未来研究应仔细量化阿片给药变量,以确定身心疗法与阿片相关结局的关联。

对床旁实践的改变

  • 作者认为MBTs可能与疼痛中度改善及阿片剂量小幅降低相关,并可能对阿片渴求与误用等阿片相关问题有治疗获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Mind-body therapies (MBTs) are emerging as potential tools for addressing the opioid crisis. Knowing whether mind-body therapies may benefit patients treated with opioids for acute, procedural, and chronic pain conditions may be useful for prescribers, payers, policy makers, and patients.

OBJECTIVE: To evaluate the association of MBTs with pain and opioid dose reduction in a diverse adult population with clinical pain.

DATA SOURCES: For this systematic review and meta-analysis, the MEDLINE, Embase, Emcare, CINAHL, PsycINFO, and Cochrane Library databases were searched for English-language randomized clinical trials and systematic reviews from date of inception to March 2018. Search logic included (pain OR analgesia OR opioids) AND mind-body therapies. The gray literature, ClinicalTrials.gov, and relevant bibliographies were also searched.

STUDY SELECTION: Randomized clinical trials that evaluated the use of MBTs for symptom management in adults also prescribed opioids for clinical pain.

DATA EXTRACTION AND SYNTHESIS: Independent reviewers screened citations, extracted data, and assessed risk of bias. Meta-analyses were conducted using standardized mean differences in pain and opioid dose to obtain aggregate estimates of effect size with 95% CIs.

MAIN OUTCOMES AND MEASURES: The primary outcome was pain intensity. The secondary outcomes were opioid dose, opioid misuse, opioid craving, disability, or function.

RESULTS: Of 4212 citations reviewed, 60 reports with 6404 participants were included in the meta-analysis. Overall, MBTs were associated with pain reduction (Cohen d = -0.51; 95% CI, -0.76 to -0.26) and reduced opioid dose (Cohen d = -0.26; 95% CI, -0.44 to -0.08). Studies tested meditation (n = 5), hypnosis (n = 25), relaxation (n = 14), guided imagery (n = 7), therapeutic suggestion (n = 6), and cognitive behavioral therapy (n = 7) interventions. Moderate to large effect size improvements in pain outcomes were found for meditation (Cohen d = -0.70), hypnosis (Cohen d = -0.54), suggestion (Cohen d = -0.68), and cognitive behavioral therapy (Cohen d = -0.43) but not for other MBTs. Although most meditation (n = 4 [80%]), cognitive-behavioral therapy (n = 4 [57%]), and hypnosis (n = 12 [63%]) studies found improved opioid-related outcomes, fewer studies of suggestion, guided imagery, and relaxation reported such improvements. Most MBT studies used active or placebo controls and were judged to be at low risk of bias.

CONCLUSIONS AND RELEVANCE: The findings suggest that MBTs are associated with moderate improvements in pain and small reductions in opioid dose and may be associated with therapeutic benefits for opioid-related problems, such as opioid craving and misuse. Future studies should carefully quantify opioid dosing variables to determine the association of mind-body therapies with opioid-related outcomes.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Garland EL, Brintz CE, Hanley AW, et al. Mind-Body Therapies for Opioid-Treated Pain: A Systematic Review and Meta-analysis. JAMA Intern Med. 2020. PMID: 31682676. doi:10.1001/jamainternmed.2019.4917

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。